Introduction
Lymphoscintigraphy, the intradermal or subcutaneous injection of a radiocolloid, has become an increasingly common technique in the past several years for mapping potential sites of nodal metastases and for predicting involvement with tumor (Croll et al., 1983) . A considerable number of agents have been evaluated as possible lymphoscintigraphic agents (Bergvist et al., 1983) . 99mTc antimony trisulfide colloid ((TcSbC) has been used extensively clinically, while we have more recently been using %Tc human serum albumin (TcHSA) for scanning (Croll et al., 1983; Froelich et al., 1984; Eberbach et al., 1987) . Radiolabeled antibodies, and most recently monoclonal antibodies have also been suggested as potentially useful imaging agents and have shown promising results in animal models and in some clinical trials (DeLand et al., 1980; Weinstein et al., 1983; Carrasquillo et al., 1986; . While some information is available regarding the rate of egress of monoclonal antibodies injected subcutaneously, little is known regarding the kinetics of uptake of these agents into normal lymph nodes or if the larger IgM is handled differently (Bergqvist et al., 1983; Wahl et al., 1985) . Similarly, relatively little is known regarding comparisons of noncolioidal TcHSA, which has been clinically useful in our practice, with the TcSbC product available for investigational use in the U.S. (Bergqvist et al., 1983; Eberbach et al., 1987) . In fact, we have recently demonstrated that small molecules such as %Tc MDP used for bone scanning can reach relatively high levels in regional lymph nodes (following S.C. administration) suggesting that the colloidal state may not be a necessary prerequisite to achieving significant levels of uptake of radiopharmaceuticals to regional lymph nodes as has heen previously suggested (Croll et al., 1983; Wallis et al., 1987) . This study was designed to delineate the rate and extent of lymph node and systemic uptake of these current and potential lymphoscintigraphic agents.
Methods
The lymphoscintigraphic agents studied included: 
TcHSA
This was made by adding 4 mCi of 99mT~ to 7 mg of human serum albumin. This was provided in kit form by Medi-Physics. This reagent was 98% devoid of free TcO; by acetone silica gel thin layer chromatography (Gelman, Ann Arbor, Mich.). One hundred PCi was given per animal (approximately 7Opg).
566.4
566.4 is a murine IgG2ak reactive with ovarian and other epithelial carcinomas (Wahl et al., 1986) . This agent was labeled using the iodogen method in which 1OOpg was reacted with 1 mCi of lz51 (ICN). Yields of over 70% were typical, with >95% purity following Biogel (Biorad) P-60 chromatography. Nine to ten PCi were given per animal.
Similar iodination conditions were used for FT166, a murine IgM reactive with bladder carcinomas (4-5 PCi injected per animal) (Liebert), and 763.24T (10-l 1 PCi injected per animal), a murine IgGlk (Wilson et al., 1982) . The purity of these antibodies was confirmed by SDS polyacrylamide gel electrophoresis (Laemmli, 1970) . Adult, female Sprague Dawley rats were selected for study. All lymphoscintigraphic agent injections were made either intravenously by the femoral vein or subcutaneously into one hind foot pad. Animals were studied in groups of 3-7. Injection volumes were 1OOpL or less. Tissues, including popliteal lymph nodes (ipsilateral and contralateral), ipsilateral and contralateral inguinal lymph nodes, blood, liver and lower leg muscle were obtained at selected intervals post-injection, weighted and counted using standard tissue processing techniques . Radioactive decay was corrected for and the results were expressed as % kg-injected dose/g. Lymph node/blood ratios were determined by dividing lymph node uptake (X kg dose/g) by blood uptake (% kg dose/g). 763.24T and FT166 were studied following S.C. administration only.
Following i.v. administration, there is high accumulation of TcSbC in the liver and spleen, compatible with the typical behavior of colloid (Table 1) . Ipsilateral popliteal node/blood ratios reached 4070/l by 4 h after S.C. injection.
*Tc HSA
Statistical analysis was by the Student's t test and analysis of variance methods.
Results

'%Tc antimony trisuljide colloid
At 10 min following the injection of TcHSA, popliteal node uptake was 12.359 + 0.61, with a node/blood ratio of 220.7. The absolute uptake in the right popliteal node increased to peak at 1 h (18.24 f 7.53), and then fell to 9.33 + 2.16 by 4 h postinjection. The popliteal node/blood ratio also fell to 38.3/l by 4 h post-injection ( Fig. 1 and Table 2 ). Blood levels were considerably higher than for TcSbC following S.C. administration. Note that liver uptake following i.v. administration is considerably less than for antimony colloid. When TcHSA was given by the i.v. route, in contrast to the S.C. route, only minimal uptake was seen in popliteal lymph nodes (Table 2) .
From 30 min until 4 h after the injection of TcSbC, there was a dramatic increase in the uptake of the agent in the ipsilateral popliteal nodes. By 4 h, the percent kg-dose/g was 231.6 + 40.2 (SD) (Fig. 1) . When given intravenously, the same dose of TcSbC produced nodal uptake of 0.0551 + 0.0106 (Table 1) .
lzsI 5G6.4 (intact &G.&k)
This agent behaved in a similar fashion to TcHSA, in that nodal uptake ipsilateral to the injected foot peaked early and then declined. Maximal node/blood ratios were achieved soon after injection as well. These node/blood ratios fell from 74/l at 20min to 6.1/l at 4 h post-injection (Table 3) . Absolute popliteal node activity also dropped with time. At 20 min post "'1 566.4 injection the ipsilateral popliteal node activity was 8.81 f 1.30, but fell to 2.24 f 0.43 at 4 h after injection.
I251 763.24T (IgGIk)
This 150,000 dalton mouse monoclonal behaved very similarly to the '25I 566.4 antibody. At 20 min post-s.c. injection 15.82 + 2.73% kg-dose/g was located within the ipsilateral popliteal lymph node, while by 4 h post-injection, this had dropped to 2.82 + 0.40. Ipsilateral popliteal node/blood ratios fell from 83.4/l to 3.71/l at 4 h post-injection (Table 4) .
12'1 FT166 (ZgM)
This 900,000 dalton mouse monoclonal behaved differently from the '*'I IgG's in terms of nodal uptake. For example, at 20min after S.C. injection, the ipsilateral popliteal node harbored 102.1 + 40.3% kg-dose/g and at 4 h still retained 32.4 + 6.4% kgdose/g (Fig. 1) . Ipsilateral node/blood ratios also were much higher than with the '25I IgG antibodies, with node/blood ratios of 1173/l at 20 min, and 224.7/l at 4 h post-injection (Table 5 ).
Discussion
Our study compares several diverse colloidal and non-colloidal lymphoscintigraphic agents in the same animal system. These data shows that TcSbC is taken up to a much higher level in lymph nodes than are '25I IgG antibodies or TcHSA. In fact, node/blood ratios in excess of several thousand are seen with TcSbC. The '*'I IgM, FT166, is taken up in the popliteal nodes far more than TcHSA or either the '*'I IgG, or the '25I IgG2a intact antibodies. At early time points, the '25I IgM has slightly higher nodal uptake than the TcSbC. The TcHSA has a behavior intermediate between the '*'I IgM and the '*'I IgG's. This was somewhat surprising, in that monomeric allumin would have a molecular weight in the 70,000 range, smaller than an intact antibody and might be expected to be less highly retained than the larger IgG's. Radiochromatographic TSK 3000 HPLC tracings of the TcHSA product we use routinely show an elution volume slightly greater than that of IgG, in the range expected for monomeric albumin. This indicates that the TcHSA is not aggregated into a larger moiety.
The 12'1 IgG antibodies, an IgG2a 566.4 (reactive with ovarian cancer) (Wahl et al., 1986 ) and the IgG, 763.24T (reactive with melanoma) (Wilson et al., 1982) both have kappa light chains, and both behave similarly in vivo. While non-specific uptake of antibodies has been described in human imaging studies, the non-specific retention of these IgG agents appears relatively low, as at 4 h the popliteal nodes had less than l/lOOth the uptake that antimony colloid possessed (Carrasquillo et al., 1986; Engelstad et al., 1986) . TcHSA was retained to a higher degree than the '25I IgG antibody in the nodes. The mechanism for these differences is unclear at present. Certainly, some antibody binding to lymph nodes could be due to F-C receptor binding to mononuclear cells in the node, however the reason for higher TcHSA uptake is unclear (Hopf et al., 1976) .
Presumedly, much of the activity we see in lymph nodes over time is related to transient passage of the '25I IgG antibodies through the nodes. The TcSbC appears to be actively sequestered by nodes, while the lz51 IgM and TcHSA appear to be taken up and retained to a greater extent than the intact lz51 IgG's.
These differences in uptake kinetics suggest that for delayed imaging of small lymph nodes, TcSbC would Radiolabeled antibodies, albumin and antimony L4Y be the agent of choice. Despite the higher node/ mental observations should be useful in rationally background ratios for TcSbC, TcHSA in our hands planning clinical and experimental studies with has produced clinically usable lymphoscintigrams of lymphoscintigraphic agents. high quality at very early time points (minutes following injection) in patients. While node/blood ratios
